Abstract:Previous studies have identified that BCR-ABL elevates cellular reactive oxygen species (ROS) through mitochondria and NAD(P)H oxidase (NOX). However, it is still unknown how BCR-ABL over-expressed cells can maintain such altered redox status, while escaping from the persistent oxidative stress-induced cell damage or apoptosis. Therefore elucidation of the mechanisms by which CML cells cope with oxidative stress will provide important insights into the molecular events leading to leukemia development and drug resistance. The major goals of this study are to investigate the role of BCR-ABL-regulated downstream cell survival factors in providing an adaptive mechanism which allows CML cells to survive in the presence of cellular oxidative stress, and to evaluate the potential therapeutic implications. Several experimental models were used to test the cellular redox status and relative sensitivity of oxidative stress-induced cell death in our study, including BCR-ABL inducible cell lines, BCR-ABL stably transformed cell lines and BCR-ABL-expressing CML blast crisis cells with different BCL-XL/BCL-2 patterns. Additionally, we established an artificial CML cell model with heterogenic BCL-XL/BCL-2 expression to assess the correlation between cell survival factor genetic background and cell sensitivity to Imatinib and oxidative stress. In this study, BCL-XL has been identified as the major survival factors responsive to BCR-ABL-promoted cellular oxidative stress and plays a dominant role in regulating the threshold of oxidative stress-induced apoptosis. The cell survival factors BCL-XL and BCL-2 differentially protect mitochondrial integrity under oxidative stress. BCL-XL is an essential survival factor in maintaining viability of the cells with the excessive ROS while BCL-2 seems to play a relatively minor role. In addition, combination of redox-modulating reagent α-phenethyl isothiocyanate (PEITC) with BCL-XL/BCL2 inhibitor ABT737 or suppression of BCL-XL expression by BCR-ABL inhibitor Gleevec dramatically sensitizes CML cell to ROS stress-induced apoptosis. These data together suggest that elevation of BCL-XL is important for the development of CML, and that redox-directed therapy may merit further clinical investigations in CML treatment. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 2007. doi:1538-7445.AM2012-2007

Metabolic Regulation of Protein N-Alpha-Acetylation by Bcl-Xl Promotes Cell Survival

Acetyl-Coenzyme A acyltransferase 2 attenuates the apoptotic effects of BNIP3 in two human cell lines.

Sensitizing non-small cell lung cancer to BCL-xL-targeted apoptosis

Acetylation of P53 Protein at Lysine 120 Up-regulates Apaf-1 Protein and Sensitizes the Mitochondrial Apoptotic Pathway*

A Conserved Hydrophobic Core At Bcl-X(L) Mediates Its Structural Stability And Binding Affinity With Bh3-Domain Peptide Of Pro-Apoptotic Protein

Bcl-xLregulates Mitochondrial Energetics by Stabilizing the Inner Membrane Potential

NatB Protects Procaspase-8 from UBR4-Mediated Degradation and Is Required for Full Induction of the Extrinsic Apoptosis Pathway

Bcl-xL Determines the Metabolic Efficiency of Neurons, Through Interaction with Mitochondrial ATP Synthase

Bcl-X<sub>L</sub>: A multifunctional anti-apoptotic protein

Perturbation of the Bcl-2 Network and an Induced Noxa/Bcl-xL Interaction Trigger Mitochondrial Dysfunction after DNA Damage*

Α NAC Inhibition of the FADD-JNK Axis Plays Anti-Apoptotic Role in Multiple Cancer Cells

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics.

Anti-apoptotic MCL-1 promotes long-chain fatty acid oxidation through interaction with ACSL1

ATF3 Repression of BCL-XL Determines Apoptotic Sensitivity to HDAC Inhibitors across Tumor Types

The N-terminus and alpha-5, alpha-6 helices of the pro-apoptotic protein Bax, modulate functional interactions with the anti-apoptotic protein Bcl-xL

Differential Roles Of Bcl-Xl And Bcl-2 In Protecting Mitochondria Against Oxidative Stress In Cml Cells

Protein Kinase C Delta Stimulates Proteasome-Dependent Degradation Of C/Ebp Alpha During Apoptosis Induction Of Leukemic Cells

Characterization of the anti-apoptotic mechanism of Bcl-B

Regulation of Cellular Apoptosis by Palmitic Acid and TNF‐alpha: Involvement of Signal Transduction Pathways from PKR to Bcl‐2

Prostate Cancer-Specific Lysine 53 Acetylation of Cytochrome c Drives Metabolic Reprogramming and Protects from Apoptosis in Intact Cells

N-acetylcysteine Induces Apoptosis Via the Mitochondria-Dependent Pathway but Not Via Endoplasmic Reticulum Stress in H9c2 Cells